Författare: Sjöholm Åke
Titel: Pacemakern i pankreas i otakt. Rubbad pulsatil insulinfrisättning terapeutiskt intressant vid typ 2-diabetes (mk) 2007 nr 32 sid 2228-9
Ämnesord:
Typ 2-diabetes
Hypoglykemiska medel
Insulin
Insulinproducerande celler
Langerhans cellöar
Pulsatilt flöde
Sök liknande artiklar
Referenser:
1.Zhang F, Zhang Q, Tengholm A, Sjöholm Å. Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion. Am J Physiol Cell Physiol. 2006 Sep;291(3):C466-75.
2.Newgard CB, McGarry JD. Metabolic coupling factors in pancreatic ß-cell signal transduction. Ann Rev Biochem 1995; 64: 689-719.
3.Sjöholm Å, Zhang Q, Welsh N, Hansson A, Larsson O, Tally M, Berggren PO. Rapid Ca2+ influx and diacylglycerol synthesis in growth hormone-mediated islet beta-cell mitogenesis. J Biol Chem. 2000 Jul 14;275(28):21033-40.
4.Thore S, Dyachok O, Tengholm A. Oscillations of phospholipase C activity triggered by depolarization and Ca2+ influx in insulin-secreting cells. J Biol Chem. 2004 May 7;279(19):19396-400.
5.Sjöholm Å. Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets. Endocrine. 1998 Aug;9(1):1-13. Review.
6.Sjöholm Å. Glucose stimulates islet beta-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms. Diabetes. 1997 Jul;46(7):1141-7.
7.Meglasson MD, Matschinsky FM. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes/Metab Rev 1986; 2: 163-214.
8.MacDonald MJ. Elusive proximal signals of ß-cells for insulin secretion. Diabetes 1990; 39: 1461-66.
9.Matschinsky FM. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996; 45: 223-41.
10.Gembal M, Detimary P, Gilon P, Gao Z-Y, Henquin J-C. Mechanisms by which glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells. J Clin Invest 1993; 91: 871-80.
11.Hansen K. Oscillations in the blood sugar in fasting normal persons. Acta Med Scand. 1923: 4: 27-58.
12.Lang DA, Matthews DR, Peto J, Turner RC. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med. 1979 Nov 8;301(19):1023-7.
13.Matthews DR, Lang DA, Burnett MA, Turner RC. Control of pulsatile insulin secretion in man. Diabetologia. 1983 Apr;24(4):231-7.
14.Lang DA, Matthews DR, Burnett M, Ward GM, Turner RC. Pulsatile, synchronous basal insulin and glucagon secretion in man. Diabetes. 1982 Jan;31(1):22-6.
15.Maki LW, Keizer J. Analysis of possible mechanisms for in vitro oscillations of insulin secretion. Am J Physiol. 1995 Mar;268(3 Pt 1):C780-91. Review.
16.Marchetti P, Scharp DW, Mclear M, Gingerich R, Finke E, Olack B, Swanson C, Giannarelli R, Navalesi R, Lacy PE. Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes. 1994 Jun;43(6):827-30.
17.Schmitz O, Brock B, Hollingdal M, Juhl CB, Porksen N. High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology. Diabetes Metab. 2002 Dec;28(6 Suppl):4S14-20. Review.
18.Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC. Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes. 1983 Jul;32(7):617-21.
19.Goodner CJ, Sweet IR, Harrison HC Jr. Rapid reduction and return of surface insulin receptors after exposure to brief pulses of insulin in perifused rat hepatocytes. Diabetes. 1988 Oct;37(10):1316-23.
20.Ravier MA, Sehlin J, Henquin JC. Disorganization of cytoplasmic Ca2+ oscillations and pulsatile insulin secretion in islets from ob/ob mice. Diabetologia. 2002 Aug;45(8):1154-63.
21.Mao CS, Berman N, Roberts K, Ipp E. Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. Diabetes. 1999 Apr;48(4):714-21.
22.Scheen AJ, Sturis J, Polonsky KS, Van Cauter E. Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging. Diabetologia. 1996 May;39(5):564-72.
23.Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 May 12;318(19):1231-9.
24.O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med. 1988 May 12;318(19):1225-30.
25.Mao CS, Berman N, Ipp E. Loss of entrainment of high-frequency plasma insulin oscillations in type 2 diabetes is likely a glucose-specific beta-cell defect. Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E50-4.
26.Grapengiesser E, Gylfe E, Hellman B. Sulfonylurea mimics the effect of glucose in inducing large amplitude oscillations of cytoplasmic Ca2+ in pancreatic beta-cells. Mol Pharmacol. 1990 Mar;37(3):461-7.
27.Westerlund J, Gylfe E, Bergsten P. Pulsatile insulin release from pancreatic islets with nonoscillatory elevation of cytoplasmic Ca2+. J Clin Invest. 1997 Nov 15;100(10):2547-51.
28.Hellman B, Gylfe E, Bergsten P, Grapengiesser E, Berts A, Liu YJ, Tengholm A, Westerlund J. Oscillatory signaling and insulin release in human pancreatic beta-cells exposed to strontium. Endocrinology. 1997 Aug;138(8):3161-5.
29.Westerlund J, Hellman B, Bergsten P. Pulsatile insulin release from mouse islets occurs in the absence of stimulated entry of Ca2+. J Clin Invest. 1996 Apr 15;97(8):1860-3.
30.Gilon P, Shepherd RM, Henquin JC. Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidenced in single pancreatic islets. J Biol Chem. 1993 Oct 25;268(30):22265-8.
31.Bergsten P, Lin J, Westerlund J. Pulsatile insulin release: role of cytoplasmic Ca2+ oscillations. Diabetes Metab. 1998 Feb;24(1):41-5. Review.
32.Westerlund J, Bergsten P. Glucose metabolism and pulsatile insulin release from isolated islets. Diabetes. 2001 Aug;50(8):1785-90.
33.Westerlund J, Ortsäter H, Palm F, Sundsten T, Bergsten P. Glucose-regulated pulsatile insulin release from mouse islets via the KATP channel-independent pathway. Eur J Endocrinol. 2001 Jun;144(6):667-75.
34.Dyachok O, Isakov Y, Sågetorp J, Tengholm A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells. Nature. 2006 Jan 19;439(7074):349-52.
35.Ortsäter H, Liss P, Lund PE, Åkerman KE, Bergsten P. Oscillations in oxygen tension and insulin release of individual pancreatic ob/ob mouse islets. Diabetologia. 2000 Oct;43(10):1313-8.
36.Thore S, Wuttke A, Tengholm A. Rapid turnover of phosphatidylinositol-4,5-bisphosphate in insulin-secreting cells mediated by Ca2+ and the ATP-to-ADP ratio. Diabetes. 2007 Mar;56(3):818-26.
37.Hagren OI, Tengholm A. Glucose and insulin synergistically activate phosphatidylinositol 3-kinase to trigger oscillations of phosphatidylinositol 3,4,5-trisphosphate in beta-cells. J Biol Chem. 2006 Dec 22;281(51):39121-7.
38.Kar S, Shankar Ray D. Sustained simultaneous glycolytic and insulin oscillations in beta-cells. J Theor Biol. 2005 Nov 7;237(1):58-66.
39.Tornheim K. Are metabolic oscillations responsible for normal oscillatory insulin
secretion? Diabetes. 1997 Sep;46(9):1375-80.
40.Cunningham BA, Richard AM, Dillon JS, Daley JT, Civelek VN, Deeney JT, Yaney
GC, Corkey BE, Tornheim K. Glucagon-like peptide 1 and fatty acids amplify pulsatile insulin secretion from perifused rat islets. Biochem J. 2003 Jan 1;369(Pt 1):173-8.
41.Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006 Nov 11;368(9548):1696-705. Review.
42.Holz GG 4th, Kuhtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature. 1993 Jan 28;361(6410):362-5.
43.Balks HJ, Holst JJ, von zur Muhlen A, Brabant G. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab. 1997 Mar;82(3):786-90.
44.Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF. Allosteric activators of glucokinase: potential role in diabetes therapy. Science. 2003 Jul 18;301(5631):370-3.
45.Efanov AM, Barrett DG, Brenner MB, Briggs SL, Delaunois A, Durbin JD, Giese U, Guo H, Radloff M, Gil GS, Sewing S, Wang Y, Weichert A, Zaliani A, Gromada J. A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology. 2005 Sep;146(9):3696-701.
46.Guertin KR, Grimsby J. Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy. Curr Med Chem. 2006;13(15):1839-43.
47.Sarabu R, Grimsby J. Targeting glucokinase activation for the treatment of type 2 diabetes--a status review. Curr Opin Drug Discov Devel. 2005 Sep;8(5):631-7. Review.
48.Aspinwall CA, Huang L, Lakey JR, Kennedy RT. Comparison of amperometric methods for detection of exocytosis from single pancreatic beta-cells of different species. Anal Chem. 1999 Dec 15;71(24):5551-6.
